Literature DB >> 31903265

Predictors of blood loss in lung transplant surgery-a single center retrospective cohort analysis.

Bastian Grande1,2, Pascal Oechslin1, Martin Schlaepfer1,3, Burkhardt Seifert4, Ilhan Inci5, Isabelle Opitz5, Donat R Spahn1, Walter Weder5, Marco Zalunardo1.   

Abstract

BACKGROUND: This retrospective study aims to identify clinical predictors of intraoperative blood loss during lung transplantation. While for other surgical specialties predictors of blood loss have been identified such as previous likewise located surgery, poor preoperative health status of patients, blood coagulation status, and use of extra corporeal circulation, predictors of blood loss during lung transplantation are not yet established.
METHODS: A total of 326 lung transplants were performed between January 2000 and February 2014 at a tertiary hospital. The primary aim was to associate blood loss with the following potential predictors: pulmonary arterial hypertension, pre- or intraoperative extracorporeal life support (ECLS), previous thoracic surgery, previous lung transplant, and Charlson Comorbidity Index (CCI). Postoperative complications and 30-day mortality were secondary endpoints of the study.
RESULTS: Median estimated blood loss during lung transplant was 1,500 mL (IQR, 1,000-2,875 mL). Pre- and intraoperative ECLS (P=0.02, P<0.001) independently increased blood loss by 59% and 107%, respectively. The higher blood loss during re-transplant marginally missed the significance level (P=0.05). Pulmonary arterial hypertension, previous thoracic surgery and high CCI were not associated with increased blood loss. As secondary outcomes, postoperative complications were more common in patients with a higher blood loss (P=0.04) but was not associated with higher 30-day mortality (P=0.18).
CONCLUSIONS: Pre- and intraoperative ECLS were significant risk factors for higher blood loss during lung transplantation. Higher blood loss was associated with higher incidence of postoperative complications but not with a higher 30-day mortality. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Blood loss; extracorporeal life support (ECLS); lung transplantation; thoracic surgery

Year:  2019        PMID: 31903265      PMCID: PMC6940236          DOI: 10.21037/jtd.2019.10.61

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

1.  Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality.

Authors:  R K Spence; J A Carson; R Poses; S McCoy; M Pello; J Alexander; J Popovich; E Norcross; R C Camishion
Journal:  Am J Surg       Date:  1990-03       Impact factor: 2.565

2.  Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation.

Authors:  Tiago N Machuca; Stephane Collaud; Olaf Mercier; Maureen Cheung; Valerie Cunningham; S Joseph Kim; Sassan Azad; Lianne Singer; Kazuhiro Yasufuku; Marc de Perrot; Andrew Pierre; Karen McRae; Thomas K Waddell; Shaf Keshavjee; Marcelo Cypel
Journal:  J Thorac Cardiovasc Surg       Date:  2014-11-21       Impact factor: 5.209

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict.

Authors:  A Steib; G Freys; C Lehmann; C Meyer; G Mahoudeau
Journal:  Can J Anaesth       Date:  2001-12       Impact factor: 5.063

5.  Predictors of high intraoperative blood loss derived by simple and objective method in adult living donor liver transplantation.

Authors:  S R Bang; H J Ahn; G S Kim; M Yang; M S Gwak; J S Ko; S H Kim; S K Lee
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

6.  Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation.

Authors:  Christian A Bermudez; Akira Shiose; Stephen A Esper; Norihisa Shigemura; Jonathan D'Cunha; Jay K Bhama; Thomas J Richards; Peter Arlia; Maria M Crespo; Joseph M Pilewski
Journal:  Ann Thorac Surg       Date:  2014-10-22       Impact factor: 4.330

7.  Comparison of single lung transplant with and without the use of cardiopulmonary bypass.

Authors:  Clare Burdett; Tanveer Butt; Jim Lordan; John H Dark; Stephen C Clark
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-19

8.  Severity of anaemia and operative mortality and morbidity.

Authors:  J L Carson; R M Poses; R K Spence; G Bonavita
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

9.  Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass.

Authors:  Fabio Ius; Christian Kuehn; Igor Tudorache; Wiebke Sommer; Murat Avsar; Dietmar Boethig; Thomas Fuehner; Jens Gottlieb; Marius Hoeper; Axel Haverich; Gregor Warnecke
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-31       Impact factor: 5.209

10.  Association of intraoperative transfusion of blood products with mortality in lung transplant recipients.

Authors:  Denise Weber; Silvia R Cottini; Pascal Locher; Urs Wenger; Paul A Stehberger; Mario Fasshauer; Reto A Schuepbach; Markus Béchir
Journal:  Perioper Med (Lond)       Date:  2013-09-27
View more
  2 in total

1.  Effect of intraoperative blood loss on postoperative pulmonary complications in patients undergoing video-assisted thoracoscopic surgery.

Authors:  Lijun Yao; Weiwei Wang
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

2.  Favorable, arduous or fatal postoperative pathway within 90 days of lung transplantation.

Authors:  Alexy Tran-Dinh; Donia Bouzid; Adnan El Kalai; Enora Atchade; Sébastien Tanaka; Brice Lortat-Jacob; Sylvain Jean-Baptiste; Nathalie Zappella; Sandrine Boudinet; Yves Castier; Hervé Mal; Pierre Mordant; Jonathan Messika; Philippe Montravers
Journal:  BMC Pulm Med       Date:  2022-08-27       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.